Akebia Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:AX9 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
29 Feb 24	Sell€8,732	Nicole Hadas	Individual	5,974	€1.46
29 Feb 24	Sell€12,659	Michel Dahan	Individual	8,661	€1.46
29 Feb 24	Sell€68,069	John Butler	Individual	46,570	€1.46
29 Feb 24	Sell€10,479	Steven Burke	Individual	7,169	€1.46
27 Feb 24	Sell€52,852	John Butler	Individual	37,733	€1.40
27 Feb 24	Sell€15,049	Michel Dahan	Individual	10,744	€1.40
01 Feb 24	Sell€37,649	Steven Burke	Individual	24,311	€1.55
01 Feb 24	Sell€71,994	John Butler	Individual	46,489	€1.55

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of AX9?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	5,704,819	2.61%
VC/PE Firms	14,202,558	6.51%
Institutions	53,894,621	24.7%
General Public	144,379,204	66.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.8%.

Top Shareholders

Top 25 shareholders own 31.15% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
6.97%	BlackRock, Inc.	15,197,207	€26.7m	30.6%	no data
6.51%	Alerce Investment Management L.P.	14,202,558	€25.0m	0%	33.16%
4.62%	The Vanguard Group, Inc.	10,070,298	€17.7m	8.56%	no data
2.18%	Geode Capital Management, LLC	4,754,464	€8.4m	4.81%	no data
1.7%	Renaissance Technologies LLC	3,717,800	€6.5m	-5.03%	0.01%
1.57%	State Street Global Advisors, Inc.	3,430,527	€6.0m	24.9%	no data
0.93%	Jacobs Levy Equity Management Inc	2,034,169	€3.6m	-2.89%	0.01%
0.92%	Muneer Satter	2,002,561	€3.5m	0%	no data
0.75%	Northern Trust Global Investments	1,635,099	€2.9m	274%	no data
0.67%	John Butler	1,467,810	€2.6m	0%	no data
0.61%	Qube Research & Technologies Ltd	1,323,729	€2.3m	-24.1%	no data
0.5%	Morgan Stanley, Investment Banking and Brokerage Investments	1,088,242	€1.9m	42.6%	no data
0.48%	Connor, Clark & Lunn Investment Management Ltd.	1,046,691	€1.8m	0.06%	0.01%
0.4%	Federated Hermes, Inc.	868,021	€1.5m	0.32%	no data
0.31%	FMR LLC	680,062	€1.2m	26.2%	no data
0.31%	Michel Dahan	672,092	€1.2m	0%	no data
0.3%	Nicole Hadas	651,243	€1.1m	0%	no data
0.26%	Charles Schwab Investment Management, Inc.	568,667	€1.0m	-0.4%	no data
0.22%	BNY Asset Management	469,708	€825.9k	-22.3%	no data
0.2%	Goldman Sachs Group, Investment Banking and Securities Investments	433,257	€761.9k	63.6%	no data
0.19%	Wellington Management Group LLP	404,718	€711.7k	0%	no data
0.17%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	380,535	€669.1k	0%	no data
0.16%	Steven Burke	342,840	€602.9k	0%	no data
0.13%	Barclays PLC Private Banking & Investment Banking Investment	273,085	€480.2k	276%	no data
0.11%	Bank of America Corporation, Asset Management Arm	248,900	€437.7k	17.7%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/23 16:26
End of Day Share Price	2024/12/23 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Akebia Therapeutics, Inc. is covered by 21 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Difei Yang	Aegis Capital Corporation
Jonathan Aschoff	Brean Capital
Jonathan Aschoff	B. Riley Wealth